We’re #8! PTO Ranks The Economic Power Of Pharma’s Patents
This article was originally published in The Pink Sheet Daily
Pharmaceuticals falls below computers, communications and electrical equipment in “patent intensity” – the ratio of patents to jobs – according to a Patent and Trademark Office report on the importance of intellectual property to the U.S. economy.
You may also be interested in...
The company isn’t providing much detail on reasons or commercial strategy going forward, but its long-term outlook, particularly in western markets, is uninspiring, burdened by generic competition and a mixed R&D track record.
Novartis intends to improve productivity and absorb pricing pressures by closing two Swiss manufacturing facilities and transferring some research to the U.S.
President Obama announce seven initiatives to help move ideas from the lab to market as he signs the Leahy-Smith America Invents Act.